Literature DB >> 21865345

Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia.

Michael J Clemente1, Marcin W Wlodarski, Hideki Makishima, Aaron D Viny, Isabell Bretschneider, Mohammad Shaik, Nelli Bejanyan, Alan E Lichtin, Eric D Hsi, Eric D His, Ronald L Paquette, Thomas P Loughran, Jaroslaw P Maciejewski.   

Abstract

T-cell large granular lymphocyte leukemia (T-LGLL) is characterized by chronic lymphoproliferation of cytotoxic T lymphocytes (CTLs) and is associated with lineage-restricted cytopenias. Introduction of T-cell receptor (TCR) variable β-chain (Vβ) monoclonal antibodies has facilitated identification and enumeration of clonal CTLs by flow cytometry. A highly skewed TCR Vβ repertoire identified by flow cytometry is strongly associated with monoclonal CDR3 regions by quantitative sequencing and positive TCRγ rearrangement assays. Therefore, Vβ expansions can serve as surrogate markers of CTL clonality to assess clonal kinetics in T-LGLL. We analyzed the TCR repertoire in 143 patients, 71 of which were available for serial measurements over 6 to 96 months. Although the majority (38/71, 54%) maintained a consistent monoclonal expansion, many (26/71, 37%) unexpectedly displayed a change in the dominant clone, whereby the original CTL clone contracted and another emerged as demonstrated by Vβ typing. Our results demonstrate that the T-cell repertoire is more dynamic in T-LGLL than recognized previously, illustrating the heterogeneity of disorders under this categorization.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865345      PMCID: PMC3204910          DOI: 10.1182/blood-2011-02-338517

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  43 in total

1.  T cell large granular lymphocyte (LGL) leukemia associated with Behcet's disease: high expression of sFasL and IL-18 of CD8 LGL.

Authors:  Takayuki Saitoh; Takafumi Matsushima; Yoriaki Kaneko; Akihiko Yokohama; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Yoshihisa Nojima; Hirokazu Murakami
Journal:  Ann Hematol       Date:  2008-01-31       Impact factor: 3.673

2.  How I treat LGL leukemia.

Authors:  Thierry Lamy; Thomas P Loughran
Journal:  Blood       Date:  2010-12-29       Impact factor: 22.113

3.  Large granular lymphocyte leukemia (LGL) in a child with hyper IgM syndrome and autoimmune hemolytic anemia.

Authors:  Brenda J Kitchen; Laurence A Boxer
Journal:  Pediatr Blood Cancer       Date:  2008-01       Impact factor: 3.167

4.  TCR-Vbeta flow cytometric analysis of peripheral blood for assessing clonality and disease burden in patients with T cell large granular lymphocyte leukaemia.

Authors:  B Feng; J L Jorgensen; Y Hu; L J Medeiros; S A Wang
Journal:  J Clin Pathol       Date:  2010-02       Impact factor: 3.411

5.  Chronic B-cell dyscrasias are an important clinical feature of T-LGL leukemia.

Authors:  Aaron D Viny; Alan Lichtin; Brad Pohlman; Thomas Loughran; Jaroslaw Maciejewski
Journal:  Leuk Lymphoma       Date:  2008-05

6.  Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway.

Authors:  Jun Yang; Xin Liu; Susan B Nyland; Ranran Zhang; Lindsay K Ryland; Kathleen Broeg; Kendall Thomas Baab; Nancy Ruth Jarbadan; Rosalyn Irby; Thomas P Loughran
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

7.  Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia.

Authors:  A B Gelb; M van de Rijn; D P Regula; J P Cornbleet; O W Kamel; D S Horoupian; M L Cleary; R A Warnke
Journal:  Hum Pathol       Date:  1994-09       Impact factor: 3.466

8.  Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy.

Authors:  Susan O'Brien; Farhad Ravandi; Todd Riehl; William Wierda; Xuelin Huang; Jeffrey Tarrand; Brandi O'Neal; Hagop Kantarjian; Michael Keating
Journal:  Blood       Date:  2007-11-26       Impact factor: 22.113

9.  T-cell large granular lymphocyte leukemia associated with myelodysplastic syndrome: a clinicopathologic study of nine cases.

Authors:  Yang O Huh; L Jeffrey Medeiros; Farhad Ravandi; Sergej Konoplev; Jeffrey L Jorgensen; Roberto N Miranda
Journal:  Am J Clin Pathol       Date:  2009-03       Impact factor: 2.493

10.  Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia.

Authors:  Sanjay R Mohan; Michael J Clemente; Manuel Afable; Heather N Cazzolli; Nelli Bejanyan; Marcin W Wlodarski; Alan E Lichtin; Jaroslaw P Maciejewski
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

View more
  31 in total

1.  Tofacitinib as a novel salvage therapy for refractory T-cell large granular lymphocytic leukemia.

Authors:  B Bilori; S Thota; M J Clemente; B Patel; A Jerez; M Afable Ii; J P Maciejewski
Journal:  Leukemia       Date:  2015-10-09       Impact factor: 11.528

2.  Somatic STAT3 mutations in large granular lymphocytic leukemia.

Authors:  Hanna L M Koskela; Samuli Eldfors; Pekka Ellonen; Arjan J van Adrichem; Heikki Kuusanmäki; Emma I Andersson; Sonja Lagström; Michael J Clemente; Thomas Olson; Sari E Jalkanen; Muntasir Mamun Majumder; Henrikki Almusa; Henrik Edgren; Maija Lepistö; Pirkko Mattila; Kathryn Guinta; Pirjo Koistinen; Taru Kuittinen; Kati Penttinen; Alun Parsons; Jonathan Knowles; Janna Saarela; Krister Wennerberg; Olli Kallioniemi; Kimmo Porkka; Thomas P Loughran; Caroline A Heckman; Jaroslaw P Maciejewski; Satu Mustjoki
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

3.  Multiple productive immunoglobulin heavy chain gene rearrangements in chronic lymphocytic leukemia are mostly derived from independent clones.

Authors:  Karla Plevova; Hana Skuhrova Francova; Katerina Burckova; Yvona Brychtova; Michael Doubek; Sarka Pavlova; Jitka Malcikova; Jiri Mayer; Boris Tichy; Sarka Pospisilova
Journal:  Haematologica       Date:  2013-09-13       Impact factor: 9.941

4.  Subclonal STAT3 mutations solidify clonal dominance.

Authors:  Cassandra M Kerr; Michael J Clemente; Peter W Chomczynski; Bartlomiej Przychodzen; Yasunobu Nagata; Vera Adema; Valeria Visconte; Alan E Lichtin; Satu Mustjoki; Tomas Radivoyevitch; Mikkael A Sekeres; Jaroslaw P Maciejewski
Journal:  Blood Adv       Date:  2019-03-26

5.  The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.

Authors:  Hanna L M Rajala; Thomas Olson; Michael J Clemente; Sonja Lagström; Pekka Ellonen; Tuija Lundan; David E Hamm; Syed Arshi Uz Zaman; Jesus M Lopez Marti; Emma I Andersson; Andres Jerez; Kimmo Porkka; Jaroslaw P Maciejewski; Thomas P Loughran; Satu Mustjoki
Journal:  Haematologica       Date:  2014-10-03       Impact factor: 9.941

6.  Patterns of somatically acquired amplifications and deletions in apparently normal tissues of ovarian cancer patients.

Authors:  Leila Aghili; Jasmine Foo; James DeGregori; Subhajyoti De
Journal:  Cell Rep       Date:  2014-05-01       Impact factor: 9.423

Review 7.  Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia.

Authors:  HeeJin Cheon; Karolina H Dziewulska; Katharine B Moosic; Kristine C Olson; Alejandro A Gru; David J Feith; Thomas P Loughran
Journal:  Curr Hematol Malig Rep       Date:  2020-04       Impact factor: 3.952

Review 8.  T-cell receptor signaling in peripheral T-cell lymphoma - a review of patterns of alterations in a central growth regulatory pathway.

Authors:  Kathrin Warner; Nicole Weit; Giuliano Crispatzu; Joan Admirand; Dan Jones; Marco Herling
Journal:  Curr Hematol Malig Rep       Date:  2013-09       Impact factor: 3.952

9.  Deep sequencing of the T-cell receptor repertoire in CD8+ T-large granular lymphocyte leukemia identifies signature landscapes.

Authors:  Michael J Clemente; Bartlomiej Przychodzen; Andres Jerez; Brittney E Dienes; Manuel G Afable; Holleh Husseinzadeh; Hanna L M Rajala; Marcin W Wlodarski; Satu Mustjoki; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2013-10-22       Impact factor: 22.113

10.  Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells.

Authors:  Cristina Gattazzo; Antonella Teramo; Francesca Passeri; Elena De March; Samuela Carraro; Valentina Trimarco; Federica Frezzato; Tamara Berno; Gregorio Barilà; Veronica Martini; Francesco Piazza; Livio Trentin; Monica Facco; Gianpietro Semenzato; Renato Zambello
Journal:  Haematologica       Date:  2014-09-05       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.